On the 1st April 2013, both the Wellcome Trust and the Research Councils UK will require that any article which attributes their funding and incurs an Article Processing Charge (APC) must be licensed using the Creative Commons Attribution license (CC-BY).
This blog posting provides an update as to those publishers who publish high volumes of Europe PMC funded research and who have put information in the public domain to confirm whether they will offer a CC-BY option.
The exclusion of a publisher from this list does NOT mean that they are not going to offer a CC-BY option; it simply means that information about this option is not in the public domain.
Over the next few weeks, I expect more publishers to make a public statement on this topic. I will update the blog to reflect this.
Publisher (and link) | CC-BY option? | Comments |
Yes | ||
Yes | This information was posted in the BMJ’s response to the House of Lords OA Inquiry (page 36) | |
Yes | ||
Yes | ||
Yes | ||
Yes | ||
Yes | CC-BY licences will incur a higher charge | |
Yes | ||
Yes | ||
Yes | ||
Yes | ||
Yes | A limited number of journals continue to use the CC-BY-NClicense, including Pharma related titles and journals published by Springer Healthcare. For these titles, Wellcome and RCUK funded authors will not be able to use the “gold” OA route | |
Yes |